NCT02324088 2021-02-21
PEGASE07
UNICANCER
Phase 3 Completed
Clinical Trials
7 trialsNCT00499122 2018-01-02
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
University of Miami
Phase 2 Completed
NCT00957125 2016-09-08
PROMIX
Karolinska University Hospital
Phase 2 Unknown
NCT00118053 2013-11-20
Trastuzumab, Docetaxel, and Carboplatin in Treating Women With Stage II, Stage III, or Inflammatory Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated
NCT00005800 2012-09-25
Doxorubicin and Docetaxel in Treating Women With Stage III Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Completed
NCT01641406 2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2 Unknown
NCT00343512 2012-04-27
Docetaxel Followed by Surgery in Treating Women With Stage II or Stage III Breast Cancer
Vanderbilt-Ingram Cancer Center
Phase 2 Terminated